Schedule 13G ownership disclosure

Context Therapeutics, Inc.

Common Stock, par value $0.001 per share · CUSIP: 21077P108

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Avidity Partners Management LP

    Shares: 9,126,176.00 · Class: 9.9%

  • Avidity Partners Management (GP) LLC

    Shares: 9,126,176.00 · Class: 9.9%

  • Avidity Capital Partners Fund (GP) LP

    Shares: 9,126,176.00 · Class: 9.9%

  • Avidity Capital Partners (GP) LLC

    Shares: 9,126,176.00 · Class: 9.9%

  • Avidity Master Fund LP

    Shares: 5,183,700.00 · Class: 5.6%

  • Avidity Private Master Fund I LP

    Shares: 7,776,296.00 · Class: 8.4%

  • Michael Gregory

    Shares: 9,126,176.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-004877
Form type
SCHEDULE 13G/A
Filer
Avidity Partners Management LP
CIK
CIK 1791827
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub